Streetbeat News

EDTXF

Spectral Medical Inc

http://www.spectraldx.com/

CEO

Paul Walker

Industry

Irradiation Apparatus Manufacturing

Open

0.41

Mkt cap

115M

Volume

High

0.41

P/E Ratio

-5.80

52-wk high

0.55

Low

0.41

Div yield

N/A

52-wk low

0.26

Spectral Medical has announced its third-quarter results and provided a corporate update. The company has enrolled 135 patients in the Tigris Trial and has strengthened its balance sheet with expected funds to complete the trial enrollment.

Portfolio Pulse from

November 08, 2024 | 1:15 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.